Medical Education Division
Our Products
On-Line Store

Google
 
Web www.brooksidepress.org

Operational Medicine 2001
GMO Manual

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Phone Consultation  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

 
 

General Medical Officer (GMO) Manual: Clinical Section

Local Anesthetics

Department of the Navy
Bureau of Medicine and Surgery

Introduction

Distribution and Elimination

Epinephrine Effects

Chemistry

Toxicity

Systemic Epinephrine Absorption

Classification

Treatment of Systemic Toxicity

Contraindications to Epinephrine

 

 

Epinephrine Solution Preparation

Introduction

Local anesthetics are drugs that block the generation and propagation of impulses in excitable tissues, most notably the spinal cord, spinal nerve roots, and peripheral nerves, as well as skeletal muscle, cardiac muscle, and the brain. This section will briefly cover the pharmacology of commonly available local anesthetics, review the maximum recommended doses, and discuss the potentially catastrophic allergic and toxic responses.

Chemistry

Classification of Local Anesthetics

Type

Clinical Uses

Usual Concentration (%)

Usual Duration (hour)

Max. Dose (mg) **

2-Chloroprocaine

Ester

Infiltration
PNB

1
2

0.5-1.0
0.5-1.0

1000 with EPI
1000 with EPI

Tetracaine

Ester

Topical

2

0.5-1.0

80

Lidocaine

Amide

Topical

Infiltration

PNB

4
0.5-1.0

1.0-1.5

0.5-1.0
1.0-2.0

1.0-2.0

500 with EPI

500 with EPI

500 with EPI

Mepivacaine

Amide

PNB

1.0-1.5

2.0-3.0

500 with EPI

Bupivacaine

Amide

PNB

0.25-0.5

4.0-12

200 with EPI

** Dose for 70 kg male. Use only as a general guide. PNB = Peripheral Nerve Block, EPI = Epinephrine

Distribution and Elimination

Although there are many local anesthetics available, the clinician should remember that lidocaine is frequently the safest overall choice and the standard by which all other local anesthetics are compared. When in doubt, use lidocaine.

  • Aminoamides are cleared from the plasma by hepatic metabolism. Active metabolites of lidocaine can contribute to toxicity even when plasma levels of lidocaine are in a therapeutic range.

  • Aminoesters are rapidly cleared from the plasma by plasma and liver cholinesterases. Plasma levels of these local anesthetics may be elevated in patients with deficient or atypical cholinesterase enzyme.

Toxicity of Local Anesthetics

  • A common problem faced by the clinician is the report by patients that they are allergic to local anesthetics. Unfortunately, most of these patients are then subjected to a lifetime of inconvenience because this diagnosis is often incorrectly established. It is estimated that less than 1 percent of all adverse reactions to local anesthetics are actually caused by a true allergic reaction. The remaining balance of reactions occur because of the rapid rise in circulating local anesthetics or the absorption of epinephrine.

  • Aminoesters are more allergenic than aminoamides because of their relationship to p-aminobenzoic acid (PABA), a metabolic by-product. Parabens are present in multidose local anesthetic solutions, other drugs, cosmetics, and foods. Prior exposure to parabens may sensitize patients to subsequent administration of local anesthetic solutions containing these materials, resulting in an allergic reaction unrelated to the local anesthetic. Using preservative free local aminoamides will eliminate the risk of paraben sensitivity.

Treatment of Systemic Toxicity

Prevention is the best solution for avoiding systemic toxicity with local anesthetics. Meticulous attention to technique and to recognition of intravascular injections with appropriate monitoring is indicated. Signs and symptoms of local anesthetic toxicity include tinnitus, perioral numbness, metallic taste in mouth, slurring of speech, and mental status changes. Oxygen should be administered at the first sign of toxicity. Should symptoms progress, maintain the patient's airway and follow advanced cardiac life support (ACLS) guidelines. Be prepared to treat for seizures. (Bretylium being used in preference to lidocaine.)

Epinephrine Effects in Local Anesthetics

Prolongs duration of anesthesia

Increases the intensity of blockade

Reduces systemic absorption

Reduces surgical bleeding

Manifestations of Systemic Epinephrine Absorption

  • Increased heart rate.

  • Increased cardiac output.

  • Decreased systemic vascular resistance.

Contraindications to the Addition of Epinephrine to Local Anesthetics

Epinephrine Solution Preparation

Solutions of epinephrine containing 5 mcg/ml (1:200,000) appear to be optimal for the reduction of surgical bleeding and systemic absorption of local anesthetics. Solutions of local anesthetics may be adjusted to contain epinephrine for vasoconstriction by manually adding 5 mcg of epinephrine to 1 ml of anesthetic solution to produce a concentration of 1:200,000.

Reviewed by CAPT C.G. Bush, MC, USN, Anesthesiology Department, Naval Hospital Groton, CT. (1999).


Approved for public release; Distribution is unlimited.

The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Operational Medicine 2001

Health Care in Military Settings

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  ·  Other Brookside Products

 

 

Advertise on this site